How it works:
- Dual GIP and GLP-1 receptor agonist.
- Reduces blood glucose and improves insulin sensitivity.
- Suppresses appetite and supports weight loss.
Recommended for:
- Patients with type 2 diabetes.
- Individuals with obesity or excess weight.
- Patients with metabolic syndrome.
- Those requiring improved glycaemic control when standard therapy is insufficient.
Studies:
- SURPASS clinical trials demonstrated significant HbA1c and body weight reduction.
- Shown to be more effective compared with GLP-1 agonist monotherapy.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)